1.Effects of extract of Ginkgo biloba with venlafaxine on brain injury in a rat model of depression.
Xiao-song QIN ; Kui-he JIN ; Bao-kun DING ; Shou-fu XIE ; Hui MA
Chinese Medical Journal 2005;118(5):391-397
BACKGROUNDRecent studies have indicated that chronic stress may give rise to brain damage, which is related to the genesis of depression. The purpose of this study is to investigate the effects of extract of Ginkgo biloba (EGb) and venlafaxine on depression.
METHODSRats were treated with chronic and comprehensive stress to create a depression model. Immunohistochemistry was used to detect the expression of brain-derived neurotrophic factor (BDNF) in the hippocampal CA3 neurons of rats treated with different drugs. Behavioral changes of these rats were also examined.
RESULTSThe expression of BDNF in the hippocampal CA3 neurons of the depression model decreased with a reduction in exploring behavior and a significant increase in fecal production. The expression of neuron nitric-oxide synthase (nNOS) protein also increased in the rats compared to normal controls. The rats treated with EGb and venlafaxine showed an increase in expression of BDNF and exploring behavior compared to untreated rats, but a decrease in nNOS and fecal production.
CONCLUSIONSRats sustain damage to the brain after being subjected to chronic and comprehensive stress. Our research has indicated that combined EGb with venlafaxine enhances the protection of neurons and decreases damage to the brain, while relieving the side effects of synthetic antidepressants.
Animals ; Antidepressive Agents, Second-Generation ; administration & dosage ; Brain Injuries ; complications ; metabolism ; Brain-Derived Neurotrophic Factor ; biosynthesis ; Cyclohexanols ; administration & dosage ; Depression ; drug therapy ; etiology ; Drugs, Chinese Herbal ; administration & dosage ; Ginkgo biloba ; chemistry ; Hippocampus ; metabolism ; Male ; Phytotherapy ; Rats ; Rats, Wistar ; Venlafaxine Hydrochloride
2.Investigation of metabolites of Triptergium wilfordii on liver toxicity by LC-MS.
Xiao-mei ZHAO ; Xin-ying LIU ; Chang XU ; Tao YE ; Cheng JIN ; Kui-jun ZHAO ; Zhi-jie MA ; Xiao-he XIAO
China Journal of Chinese Materia Medica 2015;40(19):3851-3858
In this paper, biomarkers of liver toxicity of Triptergium wilfordii based on metabolomics was screened, and mechanism of liver toxicity was explored to provide a reference for the clinical diagnosis for liver toxicity of Triptergium wilfordii. MS method was carried on the analysis to metabolic fingerprint spectrum between treatment group and control group. The potential biomarkers were compared and screened using the multivariate statistical methods. As well, metabolic pathway would be detailed description. Combined with PCA and OPLS-DA pattern recognition analysis, 20 metabolites were selected which showed large differences between model group and blank group (VIP > 1.0). Seven possible endogenous biomarkers were analyzed and identified. They were 6-phosphate glucosamine, lysophospholipid, tryptophan, guanidine acetic acid, 3-indole propionic acid, cortisone, and ubiquinone. The level changes of above metabolites indicated that the metabolism pathways of amino acid, glucose, phospholipid and hormone were disordered. It is speculated that liver damage of T. wilfordii may be associated with the abnormal energy metabolism in citric acid cycle, amino acid metabolism in urea cycle, and glucose metabolism. It will be helpful to further research liver toxicity ingredients of Triptergium wilfordii.
Animals
;
Celastraceae
;
chemistry
;
metabolism
;
toxicity
;
Chromatography, Liquid
;
methods
;
Drugs, Chinese Herbal
;
metabolism
;
toxicity
;
Liver
;
drug effects
;
metabolism
;
Male
;
Mass Spectrometry
;
methods
;
Rats
;
Rats, Sprague-Dawley
3.Molecular epidemiology of HFMD-associated pathogen coxsackievirus A6 in Fujian Province, 2011-2013.
Wei CHEN ; Yu-wei WENG ; Wen-xiang HE ; Yong-jun ZHANG ; Xiu-hui YANG ; Huang MENG ; Jian-feng XIE ; Jin-zhang WANG ; Kui-cheng ZHENG ; Yan-sheng YAN
Chinese Journal of Virology 2014;30(6):624-629
In order to characterize the molecular epidemiology of HFMD-associated Coxsackievirus A6 (CVA6) in Fujian Province, a total of 1340 specimens from non-EV71 non-CVA16 HFMD patients were collected during 2011-2013. Isolated virus strains were identified and subtyped. Full-length coding regions for the VP1 gene of the predominant serotype CVA6 isolates were amplified and sequenced. Among the 375 non-EV71 non-CVA16 HFMD cases confirmed by virus isolation and molecular subtyping, 182 (48.5%) were found to be caused by CVA6, accounting for 7.9%, 16.2% and 39.6% HFMD-associated enteroviruses in FujianProvince during 2011, 2012, and 2013, respectively. Compared with general features observed in the HFMD epidemic, no difference in CVA6-specificity or severity rates was observed between geographical origins, gender, or age groups. Nucleotide sequence analyses of VP1 genes revealed high diversity levels of 16.2%-18.6% among CVA6 strains from Fujian Province, in contrast to the prototype CVA6 strain, and showed low levels of diversity in the amino acid sequences (4.3%-6.2%). Phylogenetic analysis also indicated that CVA6 isolates from Fujian Province were distinct from the prototype strain and other isolates from abroad; however, it was homologous to domestic strains, although the Fujian isolates clustered into multiple branches. These results suggested that significant changes in the pathogenic spectrum of HFMD in Fujian Province occurred during 2011-2013, as CVA6 was one of the predominant serotypes of HFMD. CVA6 isolates from Fujian Province were co-circulating and co-evolving with other domestic strains as multiple closely related CVA6 transmission chains were observed in Fujian Province overall and within each prefecture.
Child
;
Child, Preschool
;
China
;
epidemiology
;
Enterovirus A, Human
;
classification
;
genetics
;
isolation & purification
;
Evolution, Molecular
;
Female
;
Hand, Foot and Mouth Disease
;
epidemiology
;
virology
;
Humans
;
Infant
;
Male
;
Molecular Epidemiology
;
Molecular Sequence Data
;
Phylogeny
4.Serum sCD44v6 and sE-cadherin levels in patients with esophageal squamous cell carcinoma.
Ying HE ; Jun ZHANG ; Shu-kui WANG ; Wen-bin HUANG ; Xin-guo CHEN ; Bang-shun HE ; You-cai ZHAO ; Jin-song WANG
Journal of Zhejiang University. Medical sciences 2012;41(3):305-309
OBJECTIVETo investigate the serum levels of sCD44v6 and sE-cadherin (sE-cad) in patients with esophageal squamous cell carcinoma.
METHODSThe serum samples were collected from 65 cases of esophageal squamous cell carcinoma, 32 cases of erosive esophagitis and 35 healthy subjects. Serum sCD44v6 and sE-cad levels were measured by enzyme linked immunosorbent assay (ELISA).
RESULTSThe mean levels of serum sCD44v6 and sE-cad in esophageal squamous cell carcinoma patients were significantly higher than those of erosive esophagitis patients and normal controls (both P<0.05). There was no significant difference in serum sCD44v6 and sE-cad levels between erosive esophagitis patients normal controls (P=0.566 and P=0.708, respectively). Serum sCD44v6 and sE-cad levels of esophageal cancer patients were not correlated with their clinicopathological features. Serum sCD44v6 level is not correlated with sE-cad level in squamous cell carcinoma patients(P=0.651).
CONCLUSIONSerum sCD44v6 and sE-cad might be a potential marker for screening of esophageal squamous cell carcinoma.
Adult ; Aged ; Aged, 80 and over ; Cadherins ; blood ; Carcinoma, Squamous Cell ; blood ; pathology ; Case-Control Studies ; Esophageal Neoplasms ; blood ; pathology ; Female ; Humans ; Hyaluronan Receptors ; blood ; Male ; Middle Aged
5.Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents.
Wen-ying YANG ; Qiu-he JI ; Da-long ZHU ; Jin-kui YANG ; Lu-lu CHEN ; Zhi-min LIU ; De-min YU ; Li YAN
Chinese Medical Journal 2009;122(14):1704-1708
6.Clinical and laboratory study of a case of hematidrosis.
Feng-Kui ZHANG ; Ya-Li ZHENG ; Jin-Hua LIU ; Hui-Shu CHEN ; Shi-He LIU ; Mao-Qiang XU ; Neng NIE ; Yu-Shu HAO
Chinese Journal of Hematology 2004;25(3):147-150
OBJECTIVETo study the clinical characteristics and pathogenesis of hematidrosis.
METHODSDetailed clinical manifestations and natural history of a patient with hematidrosis were presented. A series of laboratory examinations were performed, and skin pathohistologic features and ultra microscopic structures were observed.
RESULTSThe episodes of skin bleeding occurred on any site of the body spontaneously and promptly. The skin surface bloody extravasation has identical cell components as that of peripheral blood. All the results of laboratory tests were normal except a positive Trousseau's test. Skin pathohistological study revealed some intradermal bleeding and emphraxised capillaries. No abnormality was found in sweat glands, hair follicles and sebaceous glands.
CONCLUSIONThe pathological basis for hematidrosis might be a distinctive vasculitis.
Child ; Female ; Hemorrhage ; pathology ; Humans ; Skin ; blood supply ; pathology ; Skin Diseases ; pathology
7.Mutation and amplification of RIT1 gene in hepatocellular carcinoma.
Jin-tian LI ; Wei LIU ; Zhi-he KUANG ; Ru-hua ZHANG ; Han-kui CHEN ; Qi-sheng FENG
Chinese Journal of Medical Genetics 2004;21(1):43-46
OBJECTIVETo explore the mutation and amplification of RIT1 gene and their correlation with carcinogenesis of hepatocellular carcinoma (HCC).
METHODSThe polymerase chain reactioindirect sequencing method was used for detecting the mutations in the sequence of all 6 exons in the RIT1 gene of 50 HCC tissues and paratumor tissues. And the amplification of RIT1 gene was examined by fluorescence quantitative polymerase chain reaction method.
RESULTSA nucleotide 241 G --> C substitution in exon 5 of RIT1 gene was detected in one patient's HCC tissue, but not in paratumor tissue; this 241 G --> C substitution leads to Glu81Gln amino acid alteration in the conservative domain binding GTP. A nucleotide G --> C substitution in 5'-UTR (-21 bp from initial codon) was detected in all of the 50 HCC tissues and paratumor tissues, and 2- to 297-fold amplification of RIT1 gene was detected in 11 of 43 qualified cases, the amplification frequency being 25.6%.
CONCLUSIONGene amplification is one of the main activating ways of RIT1 gene in HCC, and its amplification might be correlated with HCC carcinogenesis, while point mutation might be not.
Adult ; Aged ; Base Sequence ; Carcinoma, Hepatocellular ; genetics ; DNA Mutational Analysis ; DNA, Neoplasm ; chemistry ; genetics ; Female ; Gene Amplification ; Humans ; Liver Neoplasms ; genetics ; Middle Aged ; Mutation ; Point Mutation ; ras Proteins ; genetics
8.Angiotensin II type I receptor antisense gene therapy causes inhibition of collagen I mRNA expression and proliferation of cultured hepatic stellate cells.
Li-xin LI ; Da-zhi CHEN ; Qiang HE ; Hua FAN ; Zhong-kui JIN ; Peng LI ; Jian-tao KOU ; De-hong XIE
Chinese Journal of Hepatology 2007;15(10):789-790
9.A polymorphism of kynureninase gene in a hypertensive candidate chromosomal region is associated with essential hypertension.
Yi ZHANG ; Kui-xing ZHANG ; Xin HE ; Wen-tao YUAN ; Gu-liang WANG ; Shou-yu MAO ; Ping-jin GAO ; Wei HUANG ; Ding-liang ZHU
Chinese Journal of Cardiology 2005;33(7):588-591
OBJECTIVETo identify single nucleotide polymorphisms (SNP) in the regulatory and coding regions of human kynureninase (KYNU) gene in a hypertensive candidate chromosomal region 2q14-q23 of Han Chinese, and to investigate the relationship between polymorphisms in KYNU and essential hypertension.
METHODSThe SNPs in the promoter region and exons of the KYNU gene were detected by direct DNA sequencing. Genotyping of the nonsynonymous Lys412Glu (A/G) polymorphism was performed by DHPLC technology in 456 hypertensive patients and 430 normal controls.
RESULTSSixteen SNP were identified in the KYNU gene, including 6 in the regulatory region and 2 in the coding region (both of them lead to substitution of amino acid). Significant differences between hypertensive patients and normal controls were observed for the distribution of alleles (chi(2) = 6.693, P = 0.035) and genotypes (chi(2) = 4.188, P = 0.041) of the Lys412Glu polymorphism in all subjects, and for the distribution of alleles in the subgroup of men (chi(2) = 4.424, P = 0.035).
CONCLUSIONThe Lys412Glu polymorphism of the KYNU gene in a hypertensive candidate chromosomal region is associated with essential hypertension in Han Chinese.
Adult ; Alleles ; Asian Continental Ancestry Group ; genetics ; Exons ; Female ; Gene Frequency ; Humans ; Hydrolases ; genetics ; Hypertension ; epidemiology ; genetics ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Promoter Regions, Genetic
10.A randomized, double-blind, double-dummy study comparing a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide 12.5 mg to telmisartan 80 mg in Chinese hypertensive patients who failed to respond adequately to telmisartan 80 mg.
Shao-xing CHEN ; Jin ZHANG ; Shao-liang CHEN ; Jun-zhu CHEN ; Xiao-wei YAN ; Yuan-nan KE ; Feng-he DU ; Cheng-zong ZHANG ; Yong-wen QIN ; Kui PU ; Ding-liang ZHU
Chinese Journal of Cardiology 2008;36(4):300-304
OBJECTIVETo evaluate the efficacy and safety of a fixed dose combination of telmisartan 80 mg plus hydrochlorothiazide (HCTZ) 12.5 mg (TH) to telmisartan 80 mg (T) in Chinese patients who failed to respond adequately to treatment with T.
METHODThis is a multi-center, randomized, double-blind, double-dummy clinical study. A total of 699 eligible hypertensive patients entered a one-week screening phase prior to the eight-week open-label T period. At the end of eight weeks, 345 patients who failed to respond to T (DBP > or = 90 mm Hg, 1 mm Hg = 0.133 kPa) were randomized to receive either TH (175 patients) or T (170 patients) for another eight weeks. Sitting and standing BP were taken 24 hours post-dose and adverse events were documented at visit with 4 weeks interval. Laboratory, ECG and physical examination were performed at screening, at baseline and at the final visit.
RESULTSAfter 8 weeks treatment, (1) The mean trough reduction in sitting diastolic blood pressure (SiDBP) from baseline in TH group was greater than that in T group (10.1 mm Hg vs 7.7 mm Hg, P = 0.0017). The mean trough reduction in sitting systolic blood pressure (SiSBP) from baseline was 14.2 mm Hg in TH group and 7.4 mm Hg in T group (P < 0.0001). (2) The mean trough reduction in standing DBP and standing SBP from baseline were significantly greater in TH group (8.7 mm Hg and 12.9 mm Hg) compared those in T group (7.3 mm Hg and 7.0 mmHg, P = 0.0350, P < 0.0001). (3) The number and percentage of responders in TH group (129, 74.6%) were significantly higher than in T group (100, 59.2%, P = 0.0016). (4) The incidence of the study drug-related adverse events was similar between TH and T group (3.5% vs. 3.6%, P > 0.05).
CONCLUSIONTH was more effective than T in patients not responded adequately to T in Chinese hypertensive patients.
Adult ; Aged ; Aged, 80 and over ; Angiotensin II Type 1 Receptor Blockers ; adverse effects ; therapeutic use ; Benzimidazoles ; adverse effects ; therapeutic use ; Benzoates ; adverse effects ; therapeutic use ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Humans ; Hydrochlorothiazide ; adverse effects ; therapeutic use ; Hypertension ; drug therapy ; Male ; Middle Aged ; Treatment Outcome